TandemAI

TandemAI is an integrated drug discovery contract research organization (CRO) that combines proprietary AI and physics-based computational methods with in-house high-performance computing and extensive wet-lab operations to accelerate pharmaceutical research. Its cloud-enabled, data-centric, browser-based platform, TandemViz, spans hit finding, hit-to-lead and lead optimization, digital assays and workflows, medicinal chemistry and synthesis, biological assays, and a peptide platform. TandemAI is offered as an FTE-based service model that bundles wet-lab services with complimentary access to its AI and computational tools, or as a stand-alone SaaS software license. The company merged with Perpetual Medicines and is backed by Qiming Venture Partners.

TandemAI is profiled on the APIs.io network. Tagged areas include Company, Drug Discovery, Artificial Intelligence, Computational Chemistry, and Biotechnology.

TandemAI’s developer surface includes engineering blog, support, and 5 more developer resources.

11.8/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyDrug DiscoveryArtificial IntelligenceComputational ChemistryBiotechnologyPharmaceuticalsLife SciencesContract Research OrganizationSoftware-as-a-Service

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 11.8/100 · emerging
Contract Quality 0.0 / 21
Developer Ergonomics 1.2 / 17
Access Clarity 4.7 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tandemai: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tandemai Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: tandemai
name: TandemAI
description: TandemAI is an integrated drug discovery contract research organization (CRO) that combines proprietary AI and
  physics-based computational methods with in-house high-performance computing and extensive wet-lab operations to accelerate
  pharmaceutical research. Its cloud-enabled, data-centric, browser-based platform, TandemViz, spans hit finding, hit-to-lead
  and lead optimization, digital assays and workflows, medicinal chemistry and synthesis, biological assays, and a peptide
  platform. TandemAI is offered as an FTE-based service model that bundles wet-lab services with complimentary access to its
  AI and computational tools, or as a stand-alone SaaS software license. The company merged with Perpetual Medicines and is
  backed by Qiming Venture Partners.
url: https://raw.githubusercontent.com/api-evangelist/tandemai/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://tandemai.com/wp-content/uploads/2024/02/mobile-logo.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Drug Discovery
- Artificial Intelligence
- Computational Chemistry
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Contract Research Organization
- Software-as-a-Service
tags_raw:
- Company
- Drug Discovery
- Artificial Intelligence
- Computational Chemistry
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Contract Research Organization
- SaaS
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/tandemai-domain-security.yml
- type: Website
  url: https://tandemai.com
- type: Blog
  url: https://tandemai.com/blog/
- type: Support
  url: https://tandemai.com/contact/
- type: Login
  url: https://fep.tandemviz.com/login
- type: TermsOfService
  url: https://tandemai.com/terms-of-use/
- type: PrivacyPolicy
  url: https://tandemai.com/privacy-policy/
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1